Effects of zatebradine and propranolol on canine ischemia and reperfusion-induced arrhythmias

European Journal of Pharmacology
H NaitoK Hashimoto


1,3,4,5-Tetrahydro-7,8-dimethoxy-3[3-[[2-(3, 4-dimethoxyphenyl)-ethyl]methylamino]propyl]-2H-3-benzazepin-2-one -hy drochloride (Zatebradine) is a specific bradycardiac agent, blocking the hyperpolarization-activated pacemaker current (I(f)), and thus has no negative inotropic effect. The purpose of this study was to examine whether zatebradine is effective against ischemia and reperfusion-induced arrhythmias in dogs compared to propranolol. Arrhythmia was induced by ligation of the left anterior descending coronary artery followed by reperfusion. Ischemia-induced biphasic arrhythmias were suppressed in both zatebradine and propranolol groups. During ischemia, fatal ventricular fibrillation occurred in four dogs in the control group, 0 in the zatebradine group, and two dogs in the propranolol group. Of the 31 dogs subjected to reperfusion, mortality rates in the zatebradine, propranolol, and control groups were 56%, 75%, and 86%, respectively, and there were no significant differences. In the heart beating 10 beats/min faster than the predrug heart rate by atrial pacing, both zatebradine and propranolol attenuated ischemia-induced arrhythmias but did not affect reperfusion arrhythmias. Our results suggest that I(f) and/or beta-...Continue Reading


Jan 1, 1989·The American Journal of Physiology·M BernierD J Hearse
May 1, 1987·Journal of Molecular and Cellular Cardiology·W A CoetzeeC A Muller
Oct 1, 1984·British Journal of Pharmacology·M J CurtisM J Walker
Jan 1, 1993·Circulation Research·H YuI S Cohen
Feb 1, 1996·Japanese Journal of Pharmacology·Y X XueK Hashimoto


Feb 25, 2003·Life Sciences·Robert L HamlinCynthia A Carnes
Sep 6, 2005·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Hiroshi NagaiHisayoshi Fujiwara
May 10, 2002·Journal of Cardiovascular Pharmacology and Therapeutics·Luyi SenBramah N Singh
Jan 24, 2006·Nature Medicine·Sharlene M DayJoseph M Metzger
Apr 18, 2017·Experimental and Therapeutic Medicine·Jie HouYan Zhu

Related Concepts

Zatebradine hydrochloride
Adrenergic beta-Antagonists
Cardiac Arrhythmia
Diastolic Blood Pressure
Cardiac Pacing, Artificial
Cardiotonic Agents
Canis familiaris
Dose-Response Relationship, Drug

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.